# RN624 For Pain Of Post-Herpetic Neuralgia

> **NCT00568321** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 99 (actual)

## Conditions studied

- Neuralgia, Postherpetic

## Interventions

- **DRUG:** RN624
- **DRUG:** RN624
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00568321
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-19
- **Primary completion:** 2008-12-20
- **Final completion:** 2009-01-07
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2021-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568321, "RN624 For Pain Of Post-Herpetic Neuralgia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00568321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*